Literature DB >> 15365198

Role of pancreatic stents in prevention of post-ERCP pancreatitis.

Martin L Freeman.   

Abstract

Entities:  

Mesh：

Year:  2004        PMID： 15365198

Source DB:  PubMed          Journal:  JOP        ISSN： 1590-8577


× No keyword cloud information.
  10 in total

1.  Can endoscopic palliation of large neoplasm increase the risk of pancreatitis after endoscopic retrograde cholangiopancreatography?

Authors:  Gianfranco Fanello; Fausto Fiocca; Michele Benedetti; Gabriele Martino; Michele Marengo; Roberto Luca Meniconi; Federica Papini; Piero Chirletti
Journal:  Surg Endosc       Date:  2010-05       Impact factor: 4.584

2.  History of Post-Endoscopic Retrograde Cholangiopancreatography Pancreatitis and Acute Pancreatitis as Risk Factors for Post-ERCP Pancreatitis.

Authors:  Eiji Funatsu; Atsuhiro Masuda; Mamoru Takenaka; Takashi Nakagawa; Hideyuki Shiomi; Hayato Yoshinaka; Takashi Kobayashi; Arata Sakai; Yosuke Yagi; Masaru Yoshida; Yoshifumi Arisaka; Yoshihiro Okabe; Hiromu Kutsumi; Takeshi Azuma
Journal:  Kobe J Med Sci       Date:  2017-05-15

3.  Prophylactic pancreatic stents: does size matter? A comparison of 4-Fr and 5-Fr stents in reference to post-ERCP pancreatitis and migration rate.

Authors:  Albert Pahk; Johanne Rigaux; Vijay Poreddy; Joan Smith; Firas Al-Kawas
Journal:  Dig Dis Sci       Date:  2011-04-13       Impact factor: 3.199

4.  Acute Pancreatitis-Progress and Challenges: A Report on an International Symposium.

Authors:  Elham Afghani; Stephen J Pandol; Tooru Shimosegawa; Robert Sutton; Bechien U Wu; Santhi Swaroop Vege; Fred Gorelick; Morihisa Hirota; John Windsor; Simon K Lo; Martin L Freeman; Markus M Lerch; Yoshihisa Tsuji; Gil Y Melmed; Wahid Wassef; Julia Mayerle
Journal:  Pancreas       Date:  2015-11       Impact factor: 3.327

5.  Does rectal indomethacin eliminate the need for prophylactic pancreatic stent placement in patients undergoing high-risk ERCP? Post hoc efficacy and cost-benefit analyses using prospective clinical trial data.

Authors:  B Joseph Elmunzer; Peter D R Higgins; Sameer D Saini; James M Scheiman; Robert A Parker; Amitabh Chak; Joseph Romagnuolo; Patrick Mosler; Rodney A Hayward; Grace H Elta; Sheryl J Korsnes; Suzette E Schmidt; Stuart Sherman; Glen A Lehman; Evan L Fogel
Journal:  Am J Gastroenterol       Date:  2013-01-08       Impact factor: 10.864

Review 6.  Clinical usefulness and current problems of pancreatic duct stenting for preventing post-ERCP pancreatitis.

Authors:  Yuji Sakai; Toshio Tsuyuguchi; Osamu Yokosuka
Journal:  World J Clin Cases       Date:  2014-09-16       Impact factor: 1.337

Review 7.  Pancreatitis after endoscopic retrograde cholangio-pancreatography.

Authors:  Ayman M Abdel Aziz; Glen A Lehman
Journal:  World J Gastroenterol       Date:  2007-05-21       Impact factor: 5.742

Review 8.  Sphincter of Oddi dysfunction and pancreatitis.

Authors:  M T McLoughlin; R M S Mitchell
Journal:  World J Gastroenterol       Date:  2007-12-21       Impact factor: 5.742

9.  Modified prophylactic 5-fr pancreatic duct stent enhances the rate of spontaneous dislodgement: A multicenter randomized controlled trial.

Authors:  Qibin He; Lei Wang; Chunyan Peng; Xiaoping Zou; Qiang Zhan; Yaping Xu; Qiang Liu; Junbo Qian; Lei Gong; Yingzhou Shen; Jianping Chen
Journal:  United European Gastroenterol J       Date:  2018-10-05       Impact factor: 4.623

10.  Rectal indomethacin reduces the risk of post-endoscopic retrograde cholangiopancreatography pancreatitis in low-risk patients.

Authors:  Mohamed M Abdelfatah; Eric Gochanour; Nicholas J Koutlas; Ahmed Hamed; Glenn Harvin; Mohamed O Othman
Journal:  Ann Gastroenterol       Date:  2020-05-15
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.